TOZADENANT

Biotie Therapies Corp.

Application Filed: 2015-06-30

Trademark Application Details

Status

602

Dead/Abandoned

ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

Research	OneLook Acronym Finder
Serial Number	86679017
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Domestic Representative	Yuval Marcus
Attorney Name	Yuval Marcus
Attorney Docket Number	03258/309317
Law Office Assigned	L30
Employee Name	JUN, WON KYUNG WENDY

Timeline

2015-06-30	Application Filed
2016-04-11	Abandon
2016-05-05	Location: TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED
2016-05-05	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	Biotie Therapies Corp.
Entity Statement	public limited company (plc)
Address	TykistÃ¶katu 6 Turku FI FI-20520
Legal Entity Type

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

YUVAL MARCUS
Leason Ellis Llp
1 Barker Ave Fl 5
White Plains, NY 10601-1523

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical products and preparations for mono therapy or combination therapy treatment of substance dependency and abuse, impulse-control disorders, inflammatory diseases, diseases caused by inflammatory disorders, immune disorders, autoimmune disorders, fibrotic conditions and diseases, central nervous system disorders, neurodegenerative disorders, psychiatric disorders, cognitive disorders, aging, metabolic disorders, diabetes, asthma, epilepsy, gastrointestinal disorders, and cardiovascular diseases; medical and veterinary products and preparations, namely, disposable and non-disposable injectors, sprays, inhalers and syringe pens, all sold filled with pharmaceutical preparations for mono therapy or combination therapy treatment of substance dependency and abuse, impulse-control disorders, inflammatory diseases, diseases caused by inflammatory disorders, immune disorders, autoimmune disorders, fibrotic conditions and diseases, central nervous system disorders, neurodegenerative disorders, psychiatric disorders, cognitive disorders, aging, metabolic disorders, diabetes, asthma, epilepsy, gastrointestinal disorders, and cardiovascular diseases; diagnostic products and preparations for medical and veterinary purposes, namely, antibodies for disease testing, diagnostic kits for medical and veterinary purposes consisting of antibodies for disease testing; biological products and preparations for medical and veterinary purposes, namely, antibodies, polynucleic acid molecules, polypeptides and proteins

Type Code

Type

GS0051

Pharmaceutical products and preparations for mono therapy or combination therapy treatment of substance dependency and abuse, impulse-control disorders, inflammatory diseases, diseases caused by inflammatory disorders, immune disorders, autoimmune disorders, fibrotic conditions and diseases, central nervous system disorders, neurodegenerative disorders, psychiatric disorders, cognitive disorders, aging, metabolic disorders, diabetes, asthma, epilepsy, gastrointestinal disorders, and cardiovascular diseases; medical and veterinary products and preparations, namely, disposable and non-disposable injectors, sprays, inhalers and syringe pens, all sold filled with pharmaceutical preparations for mono therapy or combination therapy treatment of substance dependency and abuse, impulse-control disorders, inflammatory diseases, diseases caused by inflammatory disorders, immune disorders, autoimmune disorders, fibrotic conditions and diseases, central nervous system disorders, neurodegenerative disorders, psychiatric disorders, cognitive disorders, aging, metabolic disorders, diabetes, asthma, epilepsy, gastrointestinal disorders, and cardiovascular diseases; diagnostic products and preparations for medical and veterinary purposes, namely, antibodies for disease testing, diagnostic kits for medical and veterinary purposes consisting of antibodies for disease testing; biological products and preparations for medical and veterinary purposes, namely, antibodies, polynucleic acid molecules, polypeptides and proteins

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2015-07-03	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2015-07-07	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2015-10-08	3 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN	2015-10-08	4 CNRT R:Renewal
NON-FINAL ACTION E-MAILED	2015-10-08	5 GNRT F:First Action
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2015-10-08	6 GNRN O:Outgoing Correspondence
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE	2016-05-05	7 ABN2 O:Outgoing Correspondence
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND	2016-05-05	8 MAB2 O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.